Julie LaHam
Sr. Account Executive Wisconsin



Guardant Health is Conquering Cancer with Data.  We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster.  To learn more about Guardant Health, visit

Guardant360 CDx is our commercially available test and is the first FDA-approved comprehensive liquid biopsy for all advanced solid tumors.  To learn more about Guardant360 CDx, visit:

Virtual Drop In

March 6th, 7:45 a.m. – 12:00 p.m. CST

Click here to join the zoom meeting
Call in only:  312-626-6799, Access Code:  993 4326 1908 #